|
AGF Enhanced U.S. Equity Income Fund - ETF (AENU)
|
As of October 31, 2026
|
|
(U.S. Dividend & Income Equity)
|
|
Underlying Index
|
|
Inception Return
(8/21/2023)
|
17.04 %
|
|
Day High/Low
|
$33.47 / $33.47
|
|
YTD Return
|
17.91 %
|
|
52Week High/Low
|
$34.91 / $28.12
|
|
|
|
|
|
NAVPS
(11/18/2026)
|
$33.46
|
|
Change
|
$0.00 / -0.01 %
|
Open / Close
(11/18/2026)
|
$33.47
/
$33.48
|
|
|
|
Management Fee
|
0.75 %
|
|
Traded Volume
|
100
|
|
Assets ($mil)
|
$16.13
|
|
Rank (1Yr)
|
91/225
|
|
Std Dev (3Yr)
|
9.51 %
|
|
Beta (3Yr)
|
0.69
|
|
Volatility Ranking (3Yr)
|
5/10
|
|
RRSP Eligibility
|
Yes
|
|
Open to Invest
|
Open
|
|
Annual Dividend
|
$2.09
|
|
Annual Yield
|
6.23 %
|
|
|
Objective
The Fund seeks to provide long-term capital appreciation by investing in a diversified portfolio of dividend-paying U.S. equity securities while mitigating volatility and generating consistent income through the use of options.
|
Fund Manager
AGF Investments Inc.
Portfolio Manager
Jeff Kay, AGF Investments Inc.
Stephen Duench, AGF Investments Inc.
Dillon Culhane, AGF Investments Inc.
Sub-Advisor
-
|
|
Asset Allocation
(As of September 30, 2026)
|
Sector Allocation
(As of September 30, 2026)
|
Geographic Allocation
(As of September 30, 2026)
|
Top 10 Holdings
| Name | Asset | Sector | Geographic | Percent |
| Cash and Cash Equivalents | Cash and Equivalents | Cash and Cash Equivalent | Canada | 17.75% |
| NVIDIA Corp | US Equity | Technology | United States | 3.99% |
| Applied Materials Inc | US Equity | Technology | United States | 3.72% |
| Government of United States of America Treasury Bill 0.00% 20-Oct-2026 | Cash and Equivalents | Cash and Cash Equivalent | United States | 3.36% |
| Advanced Micro Devices Inc | US Equity | Technology | United States | 3.09% |
| Alphabet Inc Cl C | US Equity | Technology | United States | 2.80% |
| Abbvie Inc | US Equity | Healthcare | United States | 2.68% |
| Microsoft Corp | US Equity | Technology | United States | 2.55% |
| Enbridge Inc | Canadian Equity | Energy | Canada | 2.50% |
| Pfizer Inc | US Equity | Healthcare | United States | 2.49% |
Performance Data
(As of October 31, 2026)
|
|
Return (%)
|
Annualized Return (%)
|
|
Return
|
1
Mth
|
3
Mth
|
6
Mth
|
YTD
|
1
Yr
|
3
Yr
|
5
Yr
|
10
Yr
|
|
Fund
|
-0.51
|
0.35
|
8.85
|
17.91
|
16.45
|
19.55
|
-
|
-
|
|
Benchmark
|
-2.46
|
0.98
|
8.34
|
13.84
|
11.64
|
23.67
|
14.78
|
15.91
|
|
Quartile Ranking
|
4
|
4
|
2
|
1
|
2
|
2
|
-
|
-
|
|
Calendar Return (%)
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
|
Fund
|
16.76
|
19.17
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
|
Benchmark
|
12.28
|
36.01
|
23.32
|
-12.52
|
28.16
|
16.07
|
25.18
|
3.98
|
13.80
|
8.65
|
|
Quartile Ranking
|
1
|
4
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|